Evidence map›Paper›PMID 31608409›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2020

Cytomegalovirus Seropositivity Is Associated With Increased Microbial Translocation in People Living With Human Immunodeficiency Virus and Uninfected Controls.

Rayoun Ramendra, Stéphane Isnard, John Lin, Brandon Fombuena, Jing Ouyang, Vikram Mehraj, Yonglong Zhang, Malcolm Finkelman, Cecilia Costiniuk, Bertrand Lebouché and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 48 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV).Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2023 · on this map
    Article
  10. Article
  11. COPD in People with HIV: Epidemiology, Pathogenesis, Management, and Prevention Strategies.International journal of chronic obstructive pulmonary disease · 2023
    Review
  12. Article
  13. Article
  14. Cytomegalovirus Viremia and Clinical Outcomes in Kenyan Children Diagnosed With Human Immunodeficiency Virus (HIV) in Hospital.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Observational
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Anti-cytomegalovirus Immunoglobulin G Is Linked to CD4 T-cell Count Decay in Human Immunodeficiency Virus (HIV) Elite Controllers.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 3 countries.

Rayoun RamendraChronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada.
Stéphane IsnardChronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada.
John LinChronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada.
Brandon FombuenaChronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada.
Jing OuyangChronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada.
Vikram MehrajChronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada.
Yonglong ZhangAssociates of Cape Cod Inc, Falmouth, Massachusetts, USA.
Malcolm FinkelmanAssociates of Cape Cod Inc, Falmouth, Massachusetts, USA.
Cecilia CostiniukChronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada.
Bertrand LebouchéChronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada.
Carl Chartrand-LefebvreCentre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada.
Madeleine DurandCentre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada.
Cécile TremblayDepartment of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada.
Petronela AncutaDepartment of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada.
Guy BoivinDepartment of Microbiology-Immunology and Infectious Diseases, Laval University, Quebec City, Quebec, Canada.
Jean-Pierre RoutyChronic Viral Illness Service, McGill University Health Centre, Montreal, Quebec, Canada.
McGill University · CAMcGill University Health Centre · CACape Cod Hospital · USCentre Hospitalier de l’Université de Montréal · CAChongqing Public Health Medical Center · CNUniversité Laval · CA

Funding

CIHR CTN257CIHR HB2-164064CIHR MOP 103230CIHR PTJ 166049
6 · The paper itself

Abstract

backgroundCytomegalovirus (CMV) seropositivity and anti-CMV immunoglobulin G (IgG) levels are associated with adverse health outcomes in elderly populations. Among people living with human immunodeficiency virus (PLWH), CMV seropositivity has been associated with persistent CD8 T-cell elevation and increased risk of developing non-AIDS comorbidities despite long-term antiretroviral therapy (ART). Herein, we investigated whether CMV seropositivity and elevation of anti-CMV IgG levels were associated with increased epithelial gut damage, microbial translocation, and systemic inflammation.

methodsA total of 150 PLWH (79 ART-naive and 71 ART-treated) were compared to 26 without human immunodeficiency virus (HIV) infection (uninfected controls). Plasma markers of HIV disease progression, epithelial gut damage, microbial translocation, nonspecific B-cell activation, anti-CMV and anti-Epstein-Barr virus (EBV) IgG levels, and proinflammatory cytokines were measured.

resultsCMV seropositivity and elevated anti-CMV IgG levels were associated with markers of epithelial gut damage, microbial translocation, and inflammation in PLWH and participants without HIV infection. In contrast, total nonspecific IgG, immunoglobulin M, immunoglobulin A, and anti-EBV IgG levels were not associated with these markers. CMV seropositivity was associated with markers of epithelial gut damage, microbial translocation, and inflammation independent of sociodemographic and behavioral characteristics of the study population.

conclusionsCMV-seropositive people with and without HIV had increased epithelial gut damage, microbial translocation, and inflammation. Furthermore, anti-CMV IgG levels were independently associated with increased epithelial gut damage and microbial translocation. CMV coinfection may partially explain persistent gut damage, microbial translocation, and inflammation in ART-treated PLWH.

Indexed as

CoinfectionCytomegalovirus InfectionsHIV InfectionsAgedAntibodies, ViralCytomegalovirusHIVHumansAntibodies, Viralcytomegalovirusepithelial gut damageHIVinflammationmicrobial translocation

Identifiers

PMID31608409
PMCPMC7486843
OpenAlexW2980739300

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.